DGAP-News: Tenex Health Receives CE Marking for the TX1 System -- A Pioneering Therapy for Tendon Pain
(firmenpresse) - Tenex Health
24.07.2013 12:00
---------------------------------------------------------------------------
LAKE FOREST, Calif., 2013-07-24 12:00 CEST (GLOBE NEWSWIRE) --
Tenex Health Inc., a medical device company pioneering a minimally invasive
treatment for tendon pain, announced it has received CE Marking for the
company's TX System.
'The TX System has enjoyed tremendous clinical and commercial success in the US
since its introduction in 2012. The CE Marking is an important milestone in
allowing the company to provide our revolutionary therapy to patients on a
global basis. We have already received strong interest from physicians around
the world who wish to deliver our technology to countless patients who suffer
from tendon pain. We are finalizing our strategic plan to commence our
commercial launch in select markets outside the United States,' said Jagi Gill,
Founder and CEO of Tenex Health.
The TX System has been used to treat over 6,000 patients to date. Clinical
results have demonstrated both compelling safety and meaningful clinical
outcomes, with approximately 90% of patients documenting pain-free results and
a return to full activity within weeks of treatment. The TX system has also
proven to be cost effective, as patients are treated in an outpatient setting
under local anesthesia in 20 minutes or less and with no additional need for
physical therapy or other medical treatment.
About Tenex Health, Inc.
Tenex Health, Inc. (www.tenexhealth.com) (www.tenexhealthpatient.com) develops
and markets innovative therapies for the treatment of tendon pain due to trauma
or repetitive motion injuries. The minimally invasive technique utilizes the
company's proprietary TX MicroTip(TM) handpiece to cut and debride diseased
tissue in an outpatient setting in under 20 minutes, using only a local
anesthetic. Since the surrounding healthy tendon tissue is not disturbed,
patients enjoy less discomfort and faster recovery times versus traditional
open surgical procedures.
Tenex Health, Inc.
MaryAnn Tingley
Vice-President of Marketing
949-454-7500 x 245
News Source: NASDAQ OMX
24.07.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Tenex Health
United States
Phone:
Fax:
E-mail:
Internet:
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Eurasian Minerals Reports Drill Results of 13.3 Meters Averaging 3.54% Lead, 4.62% Zinc, and 45.35 g/t Silver for the Balya Royalty Property in Turkey
Datum: 24.07.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 281234
Anzahl Zeichen: 3395
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 216 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Tenex Health Receives CE Marking for the TX1 System -- A Pioneering Therapy for Tendon Pain"
steht unter der journalistisch-redaktionellen Verantwortung von
Tenex Health (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
